Characterization, etiology, and management of neurocognitive impairment in patients with glioma: an evidentiary update [0.03%]
胶质瘤患者的神经认知障碍的特征、病因及管理：证据更新
Kyle R Noll,Jeffrey S Wefel
Kyle R Noll
Purpose of review: This review provides a summary of recent literature concerning neurocognitive functioning (NCF) in patients with glioma, including developments in assessment and characterization of NCF impairment, unde...
Isocitrate dehydrogenase mutation and microenvironment in gliomas: do immunotherapy approaches matter? [0.03%]
异柠檬酸脱氢酶突变和胶质瘤微环境：免疫治疗策略重要吗？
Michael Platten
Michael Platten
Purpose of review: Gliomas with mutations in the gene for isocitrate dehydrogenase (IDH) display a unique immune microenvironment that is distinct from IDH-wildtype gliomas. This unique immune microenvironment is shaped b...
Albert Ludolph
Albert Ludolph
Roger Collet-Vidiella,Alberto De Lorenzo,Luis Querol
Roger Collet-Vidiella
Purpose of review: Autoimmune nodopathies (AN) are a recognized distinct group of immune-mediated peripheral neuropathies with unique immunopathological features and therapeutic implications. This review synthesizes recen...
Heterogeneity of frequencies of motor neuron disease across ethnicities and geographical areas: focus on Arabic countries in the Mediterranean area [0.03%]
地中海区域不同民族和地理区域运动神经元病频率的异质性：重点关注阿拉伯国家
Giancarlo Logroscino,Stefano Giannoni-Luza,Daniele Urso et al.
Giancarlo Logroscino et al.
Purpose of review: Although amyotrophic lateral sclerosis (ALS) epidemiology has been increasingly characterized in many regions, data from Arabic countries remain limited. This review aims to summarize the current knowle...
Gergo Erdi-Krausz,Pamela J Shaw
Gergo Erdi-Krausz
Purpose of review: Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder with few treatment options available. The approval of tofersen, an antisense oligonucleotide, for SOD1-ALS by the FDA and EMA ma...
Neurochemical biomarkers of amyotrophic lateral sclerosis: recent developments [0.03%]
肌萎缩侧索硬化症的神经化学生物标志物：最新进展
Federico Verde
Federico Verde
Review purpose: To provide an overview of the recent developments in the field of neurochemical biomarkers of amyotrophic lateral sclerosis (ALS). Recent ...